Congenital Heart Futures Reauthorization Act of 2024
USA118th CongressHR-7189| House
| Updated: 11/21/2024
Gus M. Bilirakis
Republican Representative
Florida
Cosponsors (5)
Health Subcommittee, Energy and Commerce Committee
- Introduced
- In Committee
- On Floor
- Passed Chamber
- Enacted
Congenital Heart Futures Reauthorization Act of 2024 This act reauthorizes through FY2029 the National Congenital Heart Disease Research, Surveillance, and Awareness Program, which is administered by the Centers for Disease Control and Prevention. The program supports data collection, educational campaigns, and other efforts to better understand the causes and effects of congenital heart disease across various demographics. The act also requires the Department of Health and Human Services to (1) report on the awareness campaign and its efforts to support the health care workforce with respect to treating congenital heart disease, and (2) develop a strategy to improve these efforts.
Suggested Questions
Get AI-generated questions to help you understand this bill better
Timeline
Introduced in House
Referred to the House Committee on Energy and Commerce.
Referred to the Subcommittee on Health.
Forwarded by Subcommittee to Full Committee (Amended) by the Yeas and Nays: 24 - 0.
Subcommittee Consideration and Mark-up Session Held
Ordered to be Reported (Amended) by the Yeas and Nays: 43 - 0.
Committee Consideration and Mark-up Session Held
Placed on the Union Calendar, Calendar No. 429.
Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 118-517.
Latest Companion Bill Action
S 118-3757Committee on Health, Education, Labor, and Pensions. Reported by Senator Sanders with an amendment in the nature of a substitute. Without written report.
Mr. Bilirakis moved to suspend the rules and pass the bill, as amended.
Considered under suspension of the rules. (consideration: CR H5588-5589)
DEBATE - The House proceeded with forty minutes of debate on H.R. 7189.
Passed/agreed to in House: On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote. (text: CR H5588-5589)
On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote. (text: CR H5588-5589)
Motion to reconsider laid on the table Agreed to without objection.
Received in the Senate, read twice.
Passed Senate without amendment by Unanimous Consent. (consideration: CR S6466)
Passed/agreed to in Senate: Passed Senate without amendment by Unanimous Consent.
Message on Senate action sent to the House.
Presented to President.
Signed by President.
Became Public Law No: 118-107.
Health
Cardiovascular and respiratory healthHealth programs administration and fundingHealth promotion and preventive careMedical researchResearch administration and funding
Congenital Heart Futures Reauthorization Act of 2024
USA118th CongressHR-7189| House
| Updated: 11/21/2024
Congenital Heart Futures Reauthorization Act of 2024 This act reauthorizes through FY2029 the National Congenital Heart Disease Research, Surveillance, and Awareness Program, which is administered by the Centers for Disease Control and Prevention. The program supports data collection, educational campaigns, and other efforts to better understand the causes and effects of congenital heart disease across various demographics. The act also requires the Department of Health and Human Services to (1) report on the awareness campaign and its efforts to support the health care workforce with respect to treating congenital heart disease, and (2) develop a strategy to improve these efforts.
Suggested Questions
Get AI-generated questions to help you understand this bill better
Timeline
Introduced in House
Referred to the House Committee on Energy and Commerce.
Referred to the Subcommittee on Health.
Forwarded by Subcommittee to Full Committee (Amended) by the Yeas and Nays: 24 - 0.
Subcommittee Consideration and Mark-up Session Held
Ordered to be Reported (Amended) by the Yeas and Nays: 43 - 0.
Committee Consideration and Mark-up Session Held
Placed on the Union Calendar, Calendar No. 429.
Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 118-517.
Latest Companion Bill Action
S 118-3757Committee on Health, Education, Labor, and Pensions. Reported by Senator Sanders with an amendment in the nature of a substitute. Without written report.
Mr. Bilirakis moved to suspend the rules and pass the bill, as amended.
Considered under suspension of the rules. (consideration: CR H5588-5589)
DEBATE - The House proceeded with forty minutes of debate on H.R. 7189.
Passed/agreed to in House: On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote. (text: CR H5588-5589)
On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote. (text: CR H5588-5589)
Motion to reconsider laid on the table Agreed to without objection.
Received in the Senate, read twice.
Passed Senate without amendment by Unanimous Consent. (consideration: CR S6466)
Passed/agreed to in Senate: Passed Senate without amendment by Unanimous Consent.
Message on Senate action sent to the House.
Presented to President.
Signed by President.
Became Public Law No: 118-107.
Gus M. Bilirakis
Republican Representative
Florida
Cosponsors (5)
Health Subcommittee, Energy and Commerce Committee
Health
- Introduced
- In Committee
- On Floor
- Passed Chamber
- Enacted
Cardiovascular and respiratory healthHealth programs administration and fundingHealth promotion and preventive careMedical researchResearch administration and funding